Does a State Malpractice Cap Apply to PAs?
The case highlights concerns regarding malpractice caps for PAs who have DSA agreements with physicians.
Hematology/Oncology Information Center
Top April 2022 FDA Approvals
April 2022 FDA approvals include treatments for pediatric urinary tract infections, topical rosacea, vulvovaginal candidiasis, and various types of cancer.
Recent Cancer Treatment Linked to Worse COVID-19 Outcomes
A history of cancer more than 1 year before COVID-19 diagnosis not tied to increased mortality or hospitalization.
Colonoscopy Before Age 50 May Cut Colorectal Cancer Risk in Women
Reduced risk seen with earlier initiation of endoscopy, including lower risk for colorectal cancer diagnosed in women before 55 years of age.
FDA Clears Automated, Wearable 3D Breast Ultrasound Device
In 2 minutes, the portable ATUSA system automatically scans the entire breast volume and provides 3D visualization of the breast tissue.
Ovarian Cancer is Not a Silent Killer – Recognizing Its Symptoms Could Help Reduce Misdiagnosis and Late Detection
Barbara Goff, MD discusses ovarian cancer and how recognizing symptoms can lead to early detection and reduce misdiagnosis.
Vitamin D Level, Race/Ethnicity Tied to Breast Cancer Risk
Sufficient circulating vitamin D concentration linked to lower risk for breast cancer in Hispanic/Latina women.
Prostate Cancer Biopsy, Diagnoses Down During the Pandemic
However, there were no statistically significant changes in rates by race.
COVID-19 Vaccine Largely Protects Cancer Patients
However, higher risk seen for breakthrough infections and severe outcomes, especially for hematologic malignancies.
False-Positive Mammograms Found in Half of Women Screened Annually
Clinicians should continue to counsel patients that false-positive results are an expected outcome of screening mammography. Age and breast density should be factored in when deciding the frequency of screening for average-risk women.
Top March 2022 FDA Approvals
March 2022 FDA approvals include treatments for Alzheimer disease, endometrial carcinoma, metastatic melanoma, and a genetic seizure disorder.
Cumulative Lifetime Excess Weight Has Bigger Impact on CRC Risk
Role of cumulative lifetime excess weight greater than role of excess BMI measured at a single time point.
COVID’s ‘Silver Lining’: Research Breakthroughs for Chronic Disease, Cancer, and the Common Flu
COVID-19 research is expected to yield medical and scientific dividends for the treatment of influenza, cancer, cystic fibrosis, and other chronic diseases.
Niraparib With Abiraterone + Prednisone Improves Outcomes in HRR BM+ Metastatic Castration Resistant Prostate Cancer
The phase 3 MAGNITUDE study assessed niraparib in combination with abiraterone acetate plus prednisone in patients with mCRPC with or without alterations in homologous recombination repair associated genes.
Study Identifies Treatment Preferences in Advanced Renal Cell Carcinoma
The case-based study aimed to analyze the prescribing behaviors of community oncologists treating patients with aRCC.
Bladder-Sparing Therapies for Localized Muscle-Invasive Bladder Cancer Compared
The real-world study compared the efficacy of neoadjuvant chemotherapy plus immunotherapy vs chemotherapy alone in patients with cT2-4bN0-3M0-1a pathological and imaging diagnosed MIBC.
Meat Intake After Diagnosis Not Tied to Colon Cancer Outcomes
Postdiagnosis intake of unprocessed red meat, processed meat not linked with recurrence or mortality risk in patients with stage III colon cancer.
Anxiety, Depression Med Use Linked to Increased Odds of PSA Testing
Researchers used 2018 data from the National Health Interview Survey to investigate the association.
Lowering the Colorectal Cancer Screening Age for Average Risk Individuals
Investigators assessed the prevalence of and risk factors for colorectal neoplasia among patients aged 18 to 54 years.
Postendoscopy Upper Gastrointestinal Cancers Common, Less Likely to Present With Alarm Symptoms
Investigators assessed overall characteristics of postendoscopy upper gastrointestinal cancers and compared them with those of initially detected cancers.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Hematology/Oncology Information Center
Loading... 
Loading...